Obesity

41 competing products in clinical development for Obesity.

Pipeline by Phase

Pre-clinical3

Phase 114

Phase 212

Phase 37

Approved5

All Products (41)

Product	Company	Stage	Status	Hype
Tirzepatide	Eli Lilly	Approved	Recruiting	50
Orforglipron + Placebo	Eli Lilly	Phase 3	Recruiting	47
exenatide + Placebo	Eli Lilly	Approved	Completed	43
Micafungin + Micafungin	Astellas Pharma	Approved	Completed	43
Zonegran + Placebo	Eisai	Approved	Completed	43
Tirzepatide	Eli Lilly	Phase 2	Recruiting	42
MK0557	Merck	Phase 3	Completed	40
Tirzepatide + Placebo	Eli Lilly	Phase 3	Completed	40
Lorcaserin 10 mg once daily (QD) + Lorcaserin 10 mg twice a day (BID) + Matching Placebo	Eisai	Phase 3	Completed	40
Lorcaserin 10 mg once daily (QD) + Lorcaserin 10 mg twice a day (BID) + Matching Placebo	Eisai	Phase 3	Completed	40
Sibutramine Hydrochloride Monohydrate	Eisai	Phase 3	Completed	40
Lorcaserin 10 mg BID + Matching Placebo BID	Eisai	Phase 3	Completed	40
Bimagrumab + Tirzepatide + Bimagrumab Placebo + Tirzepatide Placebo	Eli Lilly	Phase 2	Active	39
Brenipatide	Eli Lilly	Phase 1	Recruiting	36
MK0493	Merck	Phase 2	Completed	35
S-2367 (velneperit)	Shionogi	Phase 2	Completed	35
Velneperit 400 mg + Orlistat 120 mg + Orlistat Placebo + Velneperit Placebo	Shionogi	Phase 2	Completed	35
S-2367 Placebo + S-2367 1600 mg q.d. 54 Weeks + S-2367 1600 mg q.d. 60 weeks	Shionogi	Phase 2	Completed	35
S-2367 Placebo + S-2367 800 mg + S-2367 1600 mg	Shionogi	Phase 2	Completed	35
S-309309 + Placebo	Shionogi	Phase 2	Completed	35
lorcaserin hydrochloride XR + Placebo	Eisai	Approved	Terminated	35
APD356	Eisai	Phase 2	Completed	35
APD356	Eisai	Phase 2	Completed	35
MBX 4291 + Placebo	MBX Biosciences	Phase 1	Recruiting	30
AMG 786	Amgen	Phase 1	Completed	29
Orforglipron + Placebo	Eli Lilly	Phase 1	Completed	29
Eloralintide + Placebo	Eli Lilly	Phase 1	Completed	29
LY3437943 + Midazolam + Warfarin + Caffeine	Eli Lilly	Phase 1	Completed	29
Nimacimab injection + Nimacimab placebo injection + Nimacimab 300 mg injection	Skye Bioscience	Phase 2	Active	29
S309309 + Itraconazole	Shionogi	Phase 1	Completed	29
S-309309 + Midazolam + Placebo	Shionogi	Phase 1	Completed	29
Placebo + Lorcaserin 10mg BID	Eisai	Phase 1	Completed	29
lorcaserin	Eisai	Phase 1	Completed	29
Lorcaserin 10mg	Eisai	Phase 1	Completed	29
Lorcaserin hydrochloride	Eisai	Phase 1	Completed	29
Oral Azelaprag (BGE-105) + Oral Placebo for Azelaprag (BGE-105) + Tirzepatide + Tirzepatide Placebo	Eli Lilly	Phase 2	Terminated	27
PG-102	Rani Therapeutics	Phase 1	Recruiting	26
Adenosine + Regadenoson	Astellas Pharma	Pre-clinical	Completed	26
Lorcaserin	Eisai	Pre-clinical	Completed	26
Lorcaserin + Placebo	Eisai	Pre-clinical	Completed	26
ZYT1 + Placebo tablets	Zydus Lifesciences	Phase 1	Terminated	21